Clinical trial

HENOX: Enoxaparine in Hemodialysis

NCT00347490 · Sanofi, Industry · Completed

Key facts

NCT number NCT00347490
Title HENOX: Enoxaparine in Hemodialysis
Official title Efficacy and Safety in Hemodialysis With Enoxaparine
Lead sponsor Sanofi, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hemodialysis
Intervention type Drug
Interventions Enoxaparine
Enrollment 100
Start date May 1, 2006
Primary completion Apr 1, 2007
Completion Jun 1, 2007
First posted Jul 4, 2006
Last update posted Jan 24, 2008
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies